Lifecore Biomedical Strengthens Investor Relations Through Back-to-Back Healthcare Conferences

2025-12-31 09:04:14

Abstract generation in progress

Lifecore Biomedical, Inc. (NASDAQ: LFCR), a fully integrated contract development and manufacturing organization specializing in sterile injectable pharmaceuticals, is set to enhance its investor relations activities with participation in two prominent conferences this November.

The company’s leadership, spearheaded by President and Chief Executive Officer Paul Josephs, will take center stage at the Jefferies 2025 Global Healthcare Conference in London from November 17-20. Josephs is scheduled to deliver a corporate presentation on Tuesday, November 18, 2025, at 9:30-9:55 a.m. GMT (4:30-4:55 a.m. ET), with webcast access provided. Beyond the formal presentation, Lifecore’s management team will engage in dedicated investor meetings to discuss the company’s capabilities in development, fill and finish operations for complex formulations and premium injectable-grade hyaluronic acid manufacturing.

Just one day later, the Lifecore investor relations roadshow continues in Nashville with participation in the Stephens Annual Investment Conference (November 18-20). Josephs will participate as a featured speaker in a fireside chat session on November 20 at 9:00-9:45 a.m. Central Time, also available via webcast. This setting will provide an interactive forum for exploring the company’s market position and strategic direction alongside one-on-one management meetings.

Investors can access live webcasts of both presentations through Lifecore’s dedicated investor website on the Investor Events & Presentations page. Recorded sessions will remain available for on-demand viewing following each conference, ensuring broader accessibility for the investment community.

Lifecore Biomedical brings over 40 years of manufacturing expertise as a partner to global and emerging biopharmaceutical companies across multiple therapeutic sectors. For additional details on the company’s investor relations initiatives and business operations, visit www.lifecore.com.

Media and Investor Contact: Ryan D. Lake, CFO Lifecore Biomedical 952-368-6244 ryan.lake@lifecore.com

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.